HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

John D Pickard Selected Research

3- (2- carboxypiperazin- 4- yl)propyl- 1- phosphonic acid (CPP)

3/2013Optimal cerebral perfusion pressure: are we ready for it?
8/2012Continuous determination of optimal cerebral perfusion pressure in traumatic brain injury.
8/2012Transcranial Doppler pulsatility index: what it is and what it isn't.
8/2012Continuous monitoring of cerebrovascular reactivity using pulse waveform of intracranial pressure.
1/2012How does moderate hypocapnia affect cerebral autoregulation in response to changes in perfusion pressure in TBI patients?
1/2012Cerebrovascular time constant: dependence on cerebral perfusion pressure and end-tidal carbon dioxide concentration.
1/2012Monitoring of the association between cerebral blood flow velocity and intracranial pressure.
5/2010A comparison study of cerebral autoregulation assessed with transcranial Doppler and cortical laser Doppler flowmetry.
1/2010Transient changes in brain tissue oxygen in response to modifications of cerebral perfusion pressure: an observational study.
1/2009Reactivity of brain tissue oxygen to change in cerebral perfusion pressure in head injured patients.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


John D Pickard Research Topics

Disease

26Brain Injuries (Brain Injury)
10/2015 - 12/2002
20Craniocerebral Trauma (Head Injury)
03/2013 - 06/2002
8Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
07/2009 - 06/2002
4Contusions
10/2015 - 11/2003
3Hypocapnia
01/2012 - 06/2004
3Hyperventilation
02/2007 - 06/2002
2Neoplasms (Cancer)
01/2015 - 03/2013
2Hypotension (Low Blood Pressure)
03/2013 - 06/2002
2Hypertension (High Blood Pressure)
03/2013 - 01/2012
2Infection
08/2012 - 10/2009
2Wounds and Injuries (Trauma)
05/2012 - 10/2007
2Intracranial Hypertension
01/2012 - 05/2010
2Closed Head Injuries
11/2010 - 02/2007
2Hyperemia
01/2010 - 02/2004
2Intracranial Vasospasm
07/2009 - 08/2005
2Brain Ischemia (Cerebral Ischemia)
10/2007 - 02/2007
2Carotid Artery Diseases
07/2004 - 12/2002
2Ischemia
02/2004 - 02/2004
1Edema
10/2015
1Cushing Syndrome
10/2015
1Headache Disorders (Headache Syndromes)
12/2013
1Acoustic Neuroma (Acoustic Neurinoma)
12/2013
1Atrophy
06/2013
1Huntington Disease (Huntington's Disease)
06/2013
1Acromegaly
03/2013
1Pituitary Neoplasms (Pituitary Adenoma)
03/2013
1Apnea
03/2013
1Acute Subdural Hematoma
01/2013
1Intracranial Hemorrhages (Intracranial Hemorrhage)
08/2012
1Hypercapnia
04/2011
1Necrosis
02/2011
1Skull Fractures (Skull Fracture)
01/2009
1Hypothermia
10/2008
1Meningioma (Meningiomas)
02/2008
1Hyperoxia
01/2008
1Ruptured Aneurysm
12/2007
1Persistent Vegetative State (Vegetative State)
10/2007
1Inflammation
10/2007
1Sepsis (Septicemia)
05/2007
1Vascular Diseases (Vascular Disease)
06/2006
1Carotid Stenosis (Carotid Artery Stenosis)
07/2004

Drug/Important Bio-Agent (IBA)

153- (2- carboxypiperazin- 4- yl)propyl- 1- phosphonic acid (CPP)IBA
03/2013 - 11/2003
12OxygenIBA
01/2009 - 06/2002
6Glucose (Dextrose)FDA LinkGeneric
01/2015 - 06/2002
4Carbon MonoxideIBA
10/2015 - 01/2004
4Lactic AcidFDA LinkGeneric
06/2014 - 01/2008
4Pravastatin (Pravachol)FDA LinkGeneric
12/2007 - 08/2005
3Carbon DioxideIBA
04/2011 - 06/2002
3Pyruvic Acid (Pyruvate)IBA
01/2009 - 01/2008
3Glutamic Acid (Glutamate)FDA Link
01/2008 - 06/2002
2Interleukin-1 (Interleukin 1)IBA
05/2014 - 10/2007
2Biological Markers (Surrogate Marker)IBA
01/2012 - 02/2011
2CytokinesIBA
02/2011 - 10/2007
2glucuronyl glucosamine glycan sulfate (Vessel)IBA
05/2010 - 05/2003
2tranilast (N 5')IBA
10/2007 - 01/2004
1EnzymesIBA
10/2015
1Matrix MetalloproteinasesIBA
10/2015
1Adrenocorticotropic Hormone (ACTH)FDA Link
10/2015
1TritiumIBA
01/2014
1Amyloid (Amyloid Fibrils)IBA
01/2014
12- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA
01/2014
1CarbonIBA
01/2014
1Insulin-Like Growth Factor I (IGF-1)IBA
03/2013
1P 11 (P-11)IBA
03/2013
1lanreotide (Somatuline)FDA Link
03/2013
1Somatostatin Receptors (Somatostatin Receptor)IBA
03/2013
1SilverIBA
08/2012
1iodoantipyrineIBA
05/2012
1VigabatrinFDA Link
01/2012
1Flumazenil (Romazicon)FDA LinkGeneric
07/2011
1CD40 Ligand (CD40L)IBA
02/2011
1platelet-derived growth factor AIBA
02/2011
1Platelet-Derived Growth FactorIBA
02/2011
1Interleukin-8 (Interleukin 8)IBA
02/2011
1InterleukinsIBA
02/2011
1Chemokine CCL5IBA
02/2011
1Hemoglobins (Hemoglobin)IBA
11/2010
13,4,4a,10b- tetrahydro- 4- propyl- 2H,5H- (1)benzopyrano(4,3- b)- 1,4- oxazin- 9- olIBA
01/2010
14,4'- Diisothiocyanostilbene- 2,2'- Disulfonic Acid (DIDS)IBA
07/2009
1ErythropoietinFDA Link
07/2009
1Glycerol (Glycerine)FDA LinkGeneric
01/2008
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2008
1LDL CholesterolIBA
12/2007
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
10/2007
1Interleukin-1alpha (Interleukin 1 alpha)IBA
10/2007
1XenonIBA
08/2007
1InosineFDA Link
04/2007
1Endothelins (Endothelin)IBA
06/2006
1salicylhydroxamic acid (SHAM)IBA
09/2004

Therapy/Procedure

6Catheters
08/2012 - 01/2008
4Critical Care
10/2011 - 01/2006
3Decompressive Craniectomy
01/2013 - 06/2011
2Radiotherapy
10/2015 - 02/2008
2Stents
12/2013 - 02/2008
1Transplantation (Transplant Recipients)
06/2013
1Cell Transplantation
06/2013
1Craniotomy
09/2012
1Lasers (Laser)
05/2010
1Rewarming
10/2008
1Hemodilution
05/2007